Here's Why Genomic Health, Inc. Gained 14.8% in September
The genetic testing leader's year-to-date momentum continued for yet another month. Should investors be concerned by the streak's abrupt end in October?

The genetic testing leader's year-to-date momentum continued for yet another month. Should investors be concerned by the streak's abrupt end in October?
Here's Why Genomic Health, Inc. Gained 14.8% in September
Here's Why Genomic Health, Inc. Gained 14.8% in September
Reviewed by Unknown
on
5:03 AM
Rating:
No comments: